Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares of China Biologic Products Holdings, Inc. Each of the undersigned acknowledges that each shall be responsible for the timely filing of any statement (including amendments) on Schedule 13D, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other persons making such filings, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of August 20, 2018.
Date: August 20, 2018
| | GL Trade Investment Limited |
| | |
| | By: | /s/ Hu Chou Hui |
| | Name: | Hu Chou Hui |
| | Title: | Director |
| | GL China Opportunities Fund L.P. |
| | |
| | By: | /s/ Zhenfu Li |
| | Name: | Zhenfu Li |
| | Title: | Authorized Signatory |
| | GL Capital Management GP L.P. |
| | |
| | By: | /s/ Zhenfu Li |
| | Name: | Zhenfu Li |
| | Title: | Authorized Signatory |
| | GL Capital Management GP Limited |
| | |
| | By: | /s/ Zhenfu Li |
| | Name: | Zhenfu Li |
| | Title: | Director |
| | GL Partners Capital Management Limited |
| | |
| | By: | /s/ Zhenfu Li |
| | Name: | Zhenfu Li |
| | Title: | Director |
